Immediate Impact
1 by Nobel laureates 3 from Science/Nature 66 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
Works of Juliette Lambert being referenced
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Juliette Lambert | 293 | 179 | 176 | 24 | 557 | |
| Sophie Rigaudeau | 232 | 123 | 162 | 21 | 547 | |
| Athanasios Galanopoulos | 204 | 111 | 156 | 40 | 478 | |
| A. Kabral | 442 | 117 | 74 | 26 | 606 | |
| Kelly Stam | 156 | 140 | 104 | 21 | 490 | |
| C. Reynolds | 285 | 49 | 161 | 22 | 529 | |
| Trudi P. Visser | 136 | 279 | 154 | 20 | 590 | |
| T Ishihara | 93 | 204 | 93 | 33 | 524 | |
| Irene V. van Blokland | 317 | 181 | 67 | 17 | 626 | |
| Christoph Tinchon | 106 | 88 | 251 | 26 | 466 | |
| Martin Schwonzen | 142 | 102 | 235 | 26 | 501 |
All Works
Login with ORCID to disown or claim papers
Loading papers...